Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002627322 | SCV002971061 | uncertain significance | not provided | 2022-02-13 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant has not been reported in the literature in individuals affected with COX15-related conditions. This variant is present in population databases (rs766283832, gnomAD 0.02%). This sequence change creates a premature translational stop signal (p.Ile347Phefs*12) in the COX15 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 42 amino acid(s) of the COX15 protein. |
Fulgent Genetics, |
RCV005025917 | SCV005658422 | likely pathogenic | Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 2 | 2024-04-12 | criteria provided, single submitter | clinical testing |